Teva not a one-man show

Regarding his perceived quick departure, Makov said he was leaving while the company was at the top, refuting speculation that he had been ousted over disagreements with Chairman Eli Hurvitz.

Israel Makov, the President and CEO of Teva, who announced his resignation three weeks ago, is confident his successor Shlomo Yanai, CEO of Makteshim Agan, despite being new to the pharmaceutical industry, will establish himself with the help of the company's management. "Teva is not a one-man show. We have the best management team in the industry," Makov told The Jerusalem Post. "We will help and teach Yanai as long as need be." Regarding his perceived quick departure, Makov said he was leaving while the company was at the top, refuting speculation that he had been ousted over disagreements with Chairman Eli Hurvitz.